Literature DB >> 19935380

The mouth: a gateway or a trap for HIV?

Daniel Malamud, Sharon M Wahl.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 19935380      PMCID： PMC2875783          DOI： 10.1097/QAD.0b013e328333525f

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  121 in total

1.  The N-terminal SRCR-SID domain of gp-340 interacts with HIV type 1 gp120 sequences and inhibits viral infection.

Authors:  Zhiwei Wu; Sang Lee; William Abrams; Drew Weissman; Daniel Malamud
Journal:  AIDS Res Hum Retroviruses       Date:  2006-06       Impact factor: 2.205

2.  Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins.

Authors:  R N Fichorova; J G Rheinwald; D J Anderson
Journal:  Biol Reprod       Date:  1997-10       Impact factor: 4.285

3.  Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells.

Authors:  Melissa K Callahan; Paul M Popernack; Shigeki Tsutsui; Linh Truong; Robert A Schlegel; Andrew J Henderson
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

Review 4.  Proteins with whey-acidic-protein motifs and cancer.

Authors:  Dominique Bouchard; Dany Morisset; Yves Bourbonnais; Guy M Tremblay
Journal:  Lancet Oncol       Date:  2006-02       Impact factor: 41.316

5.  Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.

Authors:  N K Jana; L R Gray; D C Shugars
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study.

Authors:  J M Orenstein; M S Meltzer; T Phipps; H E Gendelman
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Expression of secretory leukocyte proteinase inhibitor in the submandibular glands of AIDS patients.

Authors:  L A Rocha; P A Vargas; L F F Silva; J E Leon; A B Santos; P S Hiemstra; T Mauad
Journal:  Oral Dis       Date:  2008-01       Impact factor: 3.511

8.  Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.

Authors:  T B McNeely; M Dealy; D J Dripps; J M Orenstein; S P Eisenberg; S M Wahl
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.

Authors:  Kosuke Miyauchi; Yuri Kim; Olga Latinovic; Vladimir Morozov; Gregory B Melikyan
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

10.  Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.

Authors:  Amit Chattopadhyay; Laurie R Gray; Lauren L Patton; Daniel J Caplan; Gary D Slade; Hsaio-Chuan Tien; Diane C Shugars
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441
View more
  16 in total

1.  Short communication: HIV type 1 escapes inactivation by saliva via rapid escape into oral epithelial cells.

Authors:  Elizabeth A Dietrich; Kristin H Gebhard; Claudine E Fasching; Rodrigo A Giacaman; John C Kappes; Karen F Ross; Mark C Herzberg
Journal:  AIDS Res Hum Retroviruses       Date:  2012-01-17       Impact factor: 2.205

Review 2.  Mucosal transmission of human immunodeficiency virus.

Authors:  Denis M Tebit; Nicaise Ndembi; Aaron Weinberg; Miguel E Quiñones-Mateu
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

3.  HIV pre-exposure prophylaxis for women and infants prevents vaginal and oral HIV transmission in a preclinical model of HIV infection.

Authors:  Martina Kovarova; Uma Shanmugasundaram; Caroline E Baker; Rae Ann Spagnuolo; Chandrav De; Christopher C Nixon; Angela Wahl; J Victor Garcia
Journal:  J Antimicrob Chemother       Date:  2016-08-01       Impact factor: 5.790

4.  Systemic and mucosal differences in HIV burden, immune, and therapeutic responses.

Authors:  Sharon M Wahl; Maryann Redford; Shawna Christensen; Wendy Mack; Jon Cohn; Edward N Janoff; Jiri Mestecky; Hal B Jenson; Mahvash Navazesh; Mardge Cohen; Patricia Reichelderfer; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04-15       Impact factor: 3.731

5.  Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma.

Authors:  Jie Wen; Nikolaos G Nikitakis; Risa Chaisuparat; Teresa Greenwell-Wild; Maria Gliozzi; Wenwen Jin; Azita Adli; Niki Moutsopoulos; Tanxia Wu; Gary Warburton; Sharon M Wahl
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

Review 6.  Intestinal macrophages and response to microbial encroachment.

Authors:  P D Smith; L E Smythies; R Shen; T Greenwell-Wild; M Gliozzi; S M Wahl
Journal:  Mucosal Immunol       Date:  2010-10-20       Impact factor: 7.313

Review 7.  Detecting viruses by using salivary diagnostics.

Authors:  Paul L A M Corstjens; William R Abrams; Daniel Malamud
Journal:  J Am Dent Assoc       Date:  2012-10       Impact factor: 3.634

8.  Aberrant host defense against Leishmania major in the absence of SLPI.

Authors:  Nancy McCartney-Francis; Wenwen Jin; Yasmine Belkaid; George McGrady; Sharon M Wahl
Journal:  J Leukoc Biol       Date:  2014-07-16       Impact factor: 4.962

9.  Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study.

Authors:  Mariia Patyka; Daniel Malamud; Drew Weissman; William R Abrams; Zoya Kurago
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

10.  Oral and vaginal epithelial cell lines bind and transfer cell-free infectious HIV-1 to permissive cells but are not productively infected.

Authors:  Arinder Kohli; Ayesha Islam; David L Moyes; Celia Murciano; Chengguo Shen; Stephen J Challacombe; Julian R Naglik
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.